A. Alm et al., EFFECTS ON INTRAOCULAR-PRESSURE AND SIDE-EFFECTS OF 0.005-PERCENT LATANOPROST APPLIED ONCE-DAILY, EVENING OR MORNING - A COMPARISON WITH TIMOLOL, Ophthalmology, 102(12), 1995, pp. 1743-1752
Purpose: To compare the effect on intraocular pressure (IOP) and side
effects of 0.005% latanoprost applied once daily, morning or evening,
with 0.5% timolol applied twice daily. Methods: A 6-month randomized,
double-masked, multicenter study with three parallel groups was undert
aken. Two hundred sixty-seven patients were randomized, 84 to timolol,
89 to latanoprost in the morning for 3 months and then in the evening
for another 3 months, and 94 to latanoprost with the treatment schedu
le reversed. Results: After 6 months, timolol reduced diurnal IOP from
24.6 to 17.9 mmHg (27%); latanoprost applied in the morning, from 25.
5 to 17,7 mmHg (31%); and latanoprost applied in the evening, from 24.
8 to 16.2 mmHg (35%), The efficacy of latanoprost applied in the eveni
ng was statistically superior to latanoprost applied in the morning an
d to timolol (P < 0.001). Latanoprost induced a slight increase in con
junctival hyperemia in 31.4% of treated patients, compared with 15.9%
for timolol. Sporadic episodes of mild punctate corneal epithelial ero
sions were three times as frequent in latanoprost-treated eyes as in t
imolol-treated eyes. The most significant ocular side effect was incre
ased pigmentation of the iris observed in five and suspected in seven
more latanoprost-treated eyes, All these eyes had a mixed green-brown
or blue/gray-brown iris color. Timolol reduced heart rate by 3 beats/m
inute (P < 0.005), Conclusions: The effect on diurnal IOP of latanopro
st applied once daily in the evening is superior to that of timolol. T
he main difference in side effects is increased pigmentation of the ir
is induced by latanoprost, most likely due to stimulation of melanogen
esis in iris stromal melanocytes.